Saudi Central Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.24M Buy
142,922
+67,780
+90% +$3.89M 0.11% 119
2026
Q1
$4.56M Buy
+75,142
New +$4.38M 0.1% 104
2025
Q2
Sell
-798
Closed -$48.7K 121
2025
Q1
$48.7K Buy
+798
New +$46.5K 0.26% 80

Other funds holding BMY

Saudi Central Bank's BMY Position: Q2 2026 in Review

Saudi Central Bank increased its Bristol-Myers Squibb (BMY) stake by 90% in Q2 2026, buying an estimated $3.89M and bringing the position to 142,922 shares worth $8.24M. The position accounts for 0.11% of the portfolio, ranked #119.

Saudi Central Bank first reported a position in BMY in Q1 2025 and has held it in 3 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Saudi Central Bank held 142,922 shares of Bristol-Myers Squibb worth $8.24M as of Q2 2026.
  • Saudi Central Bank bought 67,780 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.89M.
  • Bristol-Myers Squibb made up 0.11% of Saudi Central Bank's portfolio in Q2 2026, its #119 holding.
  • Saudi Central Bank first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 3 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.